Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine

Anticoagulant citrate phosphate dextrose adenine

Drug class: Calculi Dissolution Agent, Anti-coagulant

The FDA’s “Established Pharmacologic Class”: the group of medicines that work in a similar way.

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Anticoagulant citrate phosphate dextrose adenine key facts

Drug class
Calculi Dissolution Agent
Used for
1. (source)
Prescription or over the counter
Prescription (Rx)
Generic available
No generic listed by the FDA
Latest FDA recall
None listed

Sources: FDA label (October 10, 2024); FDA NDC Directory (November 13, 2026); FDA enforcement reports (November 10, 2026). Not medical advice.

Quick answers

What is Anticoagulant citrate phosphate dextrose adenine used for?
The FDA-approved label (Teruflex Blood Bag System with Diversion Blood Sampling Arm 70 Ml CPDA-1, Terumo Corporation, October 10, 2024) says: “1. INDICATIONS AND USAGE 1.1. Read these instructions carefully before use. 1.2. Rx ONLY. 1.3. Intended for the collection, processing and preservation of Whole Blood and blood components. Not intended for direct intravenous infusion. 1.4. For the collection of 450 mL ±10% or 500 mL ±10% Whole Blood. 1.5. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Anticoagulant citrate phosphate dextrose adenine have a boxed warning?
No. None of the 14 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Anticoagulant citrate phosphate dextrose adenine?
No current shortage is listed by the FDA for the products of this medicine (FDA data from November 13, 2026).
Has Anticoagulant citrate phosphate dextrose adenine been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Anticoagulant citrate phosphate dextrose adenine?
2 companies list prescription products of Anticoagulant citrate phosphate dextrose adenine in the FDA NDC Directory, including Fenwal, Inc. and Terumo Corporation.

What Anticoagulant citrate phosphate dextrose adenine is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

1. INDICATIONS AND USAGE 1.1. Read these instructions carefully before use. 1.2. Rx ONLY. 1.3. Intended for the collection, processing and preservation of Whole Blood and blood components. Not intended for direct intravenous infusion. 1.4. For the collection of 450 mL ±10% or 500 mL ±10% Whole Blood. 1.5. …

— FDA label: Teruflex Blood Bag System with Diversion Blood Sampling Arm 70 Ml CPDA-1, Terumo Corporation, effective October 10, 2024. Read the full label on DailyMed →

Label quoted: the one for the most common form (solution, intravenous), Teruflex Blood Bag System with Diversion Blood Sampling Arm 70 Ml CPDA-1, Terumo Corporation; it covers 1 product in the FDA NDC Directory. The side effects, interactions, dosage and pregnancy quotes below come from this same label.

The FDA has 14 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 14 FDA labels for this medicine have a boxed warning.

Anticoagulant citrate phosphate dextrose adenine dosage

Quoted from the “Dosage and Administration” section of the FDA-approved label. Your own dose is the one your doctor prescribes: do not change it on your own.

2. DOSAGE AND ADMINISTRATION 2.1. To open blister package, peel cover film back 4/5 of its length. 2.2. Prepare the blood bag following your institution's standard operating procedures. 2.2.1. Materials Needed: VENOJECT II Tube Holder (code P-1316R) or equivalent VENOJECT II Multi-Sample Luer Adapter (code MN*2000T) or equivalent Evacuated blood collection tubes (glass or plastic) 2.3.

Read more of this section

Make a loose knot in the donor tubing below the "Y" and CLIKTIP (inline closure device) unless alternate methods are used to seal the tubing at the end of collection. 2.4. Temporarily clamp donor tubing between the phlebotomy needle and the "Y". 2.5. Close the White Clamp below the diversion pouch. 2.6. Assemble the luer adapter and the tube holder. 2.6.1. Connect the VENOJECT II Multi-Sample Luer Adapter to the VENOJECT II Tube Holder (or equivalent) (Fig. 1). 2.6.2. Twist and snap to remove the blue port cap at the end of the Diversion Blood Sampling Arm (Fig. 2a). 2.6.3. Insert the Holder/Luer assembly in the female luer port (Fig. 2b). 2.6.4. NOTE: Alternatively, steps 2.6.1., 2.6.2., and 2.6.3. (above) may be performed at any time during bag preparation or after the blood is collected into the diversion pouch. 2.7. Suspend the collection bag as far as possible below the donor's arm. 2.8. Apply blood pressure cuff or tourniquet to donor's arm. Disinfect site of phlebotomy according to institutional standard operating procedures. If blood pressure cuff is used, inflate to approximately 60 mmHg. 2.9. Remove the needle cover and perform phlebotomy. Remove the temporary clamp on the donor tubing to permit blood flow into the Diversion Blood Sampling Arm pouch. 2.9.1. CAUTION: Do not touch the needle after removing the needle cover. 2.9.2. CAUTION: Assure that the White Clamp below the pouch is closed prior to initiating phlebotomy. 2.10. Secure the needle safety device in place following the device instructions provided on the reverse side. 2.11. Secure donor tubing to donor's arm. 2.12. Position the diversion pouch with the notches up and the Tube Holder/Luer Adapter assembly (or port cap) down. When the level of blood in the pouch is approximately in line with the notches, the diversion pouch is full (Fig. 3a). 2.12.1. NOTE: The approximate fill volume of the pouch at the notches is 35 mL. 2.13. Permanently seal the tubing between the "Y" and the diversion pouch to maintain a closed system using an aluminum clip or a tube sealer approved for use with tubing connected to a donor (Fig. 3b). 2.13.1. CAUTION: Do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose. 2.14. To initiate blood flow into the collection bag, break the CLIKTIP between the "Y" and the collection bag. 2.15. To avoid clot formation, collect samples as soon as possible from the diversion pouch as follows (Fig. 3b). 2.15.1. CAUTION: Do not collect donor test samples until the tubing between the "Y" and the diversion pouch is permanently sealed. 2.15.2. Open the White Clamp on the tubing below the pouch to open the pathway for sampling. 2.15.3.

— FDA label: Teruflex Blood Bag System with Diversion Blood Sampling Arm 70 Ml CPDA-1, Terumo Corporation, effective October 10, 2024. This is part of the section. Read the full label on DailyMed →

Forms and how it is given

Dosage formsSolution
RouteIntravenous
Prescription products14 in the FDA NDC Directory
Brand namesCPDA-1, Teruflex Blood with Diversion Blood Sampling Arm 70 Ml CPDA-1, Teruflex Blood Bag System with Diversion Blood Sampling Arm 70 Ml CPDA-1, Teruflex Blood Anticoagulant Citrate Phosphate Dextrose Adenine (Cpda-1) for Collection of 450ml of Blood

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

No Drugs@FDA application is linked to these products.

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

SPL set ID of the quoted label86b3a329-c83f-4977-92f5-0e9dfe1872d7
FDA labels (SPL)14
Active ingredients (FDA)ADENINE / ANHYDROUS CITRIC ACID / DEXTROSE MONOHYDRATE / SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE / TRISODIUM CITRATE DIHYDRATE

Next steps

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Teruflex Blood Bag System with Diversion Blood Sampling Arm 70 Ml CPDA-1, Terumo Corporation, effective October 10, 2024; via openFDA, FDA data exported November 13, 2026, retrieved November 14, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers